- Home
- ATAI vs GCO Comparison
ATAI vs GCO Comparison
Compare ATAI & GCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATAI
- GCO
- Stock Information
- Founded
- ATAI 2018
- GCO 1924
- Country
- ATAI Germany
- GCO United States
- Employees
- ATAI N/A
- GCO N/A
- Industry
- ATAI Biotechnology: Pharmaceutical Preparations
- GCO Clothing/Shoe/Accessory Stores
- Sector
- ATAI Health Care
- GCO Consumer Discretionary
- Exchange
- ATAI Nasdaq
- GCO Nasdaq
- Market Cap
- ATAI 444.7M
- GCO 359.6M
- IPO Year
- ATAI 2021
- GCO N/A
- Fundamental
- Price
- ATAI $4.66
- GCO $32.84
- Analyst Decision
- ATAI Strong Buy
- GCO Buy
- Analyst Count
- ATAI 3
- GCO 3
- Target Price
- ATAI $13.33
- GCO $32.67
- AVG Volume (30 Days)
- ATAI 5.2M
- GCO 233.9K
- Earning Date
- ATAI 08-14-2025
- GCO 08-28-2025
- Dividend Yield
- ATAI N/A
- GCO N/A
- EPS Growth
- ATAI N/A
- GCO N/A
- EPS
- ATAI N/A
- GCO N/A
- Revenue
- ATAI $2,309,000.00
- GCO $2,362,215,000.00
- Revenue This Year
- ATAI $661.36
- GCO $2.53
- Revenue Next Year
- ATAI N/A
- GCO $2.01
- P/E Ratio
- ATAI N/A
- GCO N/A
- Revenue Growth
- ATAI 510.85
- GCO 2.66
- 52 Week Low
- ATAI $1.03
- GCO $16.19
- 52 Week High
- ATAI $5.34
- GCO $44.80
- Technical
- Relative Strength Index (RSI)
- ATAI 58.92
- GCO 61.76
- Support Level
- ATAI $4.50
- GCO $31.26
- Resistance Level
- ATAI $4.99
- GCO $33.86
- Average True Range (ATR)
- ATAI 0.35
- GCO 1.96
- MACD
- ATAI -0.04
- GCO 0.00
- Stochastic Oscillator
- ATAI 35.87
- GCO 75.55
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.
About GCO Genesco Inc.
Genesco Inc. sells footwear, headwear, sports apparel, and accessories through four main segments. The Journeys Group generates the highest revenue, encompassing the Journeys, Journeys Kidz, and Little Burgundy brands, along with e-commerce and catalog sales. The Schuh Group targets teenagers and young adults aged 16 to 24, focusing on casual and athletic footwear. The Johnston & Murphy Group operates retail shops and factory stores across the United States. Finally, the Genesco Brands Group designs and sources licensed footwear for brands like Levi's, Dockers, and G.H. Bass.